The impact of Covid-19 on people under opioid substitution treatment.

Q3 Medicine
Georgios Tzeferakos, Sofia Koutelou, Maria Tritari, Marina Skourteli, Christos Kouimtsidis, Konstantinos Kokkolis, Stylianos Stylianidis
{"title":"The impact of Covid-19 on people under opioid substitution treatment.","authors":"Georgios Tzeferakos,&nbsp;Sofia Koutelou,&nbsp;Maria Tritari,&nbsp;Marina Skourteli,&nbsp;Christos Kouimtsidis,&nbsp;Konstantinos Kokkolis,&nbsp;Stylianos Stylianidis","doi":"10.22365/jpsych.2022.092","DOIUrl":null,"url":null,"abstract":"<p><p>Given the aggravation on the general population's quality of life due to covid-19 and the vulnerability of People Who Use Drugs (PWUD) to acute stress, the aim of the current study was to better comprehend the impact of covid-19 on quality of life and mental health of PWUD as well as their drug use patterns. Another study had been conducted prior to the covid-19 outbreak, which assessed quality of life, indicative PTSD symptoms, and drug use patterns of people who were attending an Opioid Substitution Treatment (OST), in Athens, Greece. As a continuation of the aforementioned study, the same variables were assessed in May and June 2020, after the first lockdown measures. 104 patients agreed to participate. The World Health Organization Quality of Life Questionnaire (WHOQOL) and the Post-Traumatic Stress Scale (PCL-C) were used as well as toxicology tests. The only statistically significant outcome was a reduction regarding the dimension referring to the relationship between the individual and their environment. People with low quality of life were found to experience more severe Post- Traumatic Stress Disorder (PTSD) symptoms after lockdown comparing to those with high quality of life. There was also a statistically non-significant increase in PTSD scores before and after lockdown measures. Regarding drug use patterns, the present research reveals an overall decline in drug use during quarantine. There was a statistically significant decrease in opioid (22.3%) and in benzodiazepine (35%) use after lockdown. Also, a statistically significant increase in mean scores of indicative PTSD symptoms of people who decreased opioid use during and after lockdown measures was found. In regards to amphetamine use, research findings underline a non-significant increase in use (8.7%). The pandemic's impact on the life of people on opioid substitution treatment should be taken into consideration and further studies need to be conducted in order to protect this populations' quality of life and maximize the potential benefits such as reduced access to illicit substances.</p>","PeriodicalId":20741,"journal":{"name":"Psychiatrike = Psychiatriki","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Psychiatrike = Psychiatriki","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22365/jpsych.2022.092","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Given the aggravation on the general population's quality of life due to covid-19 and the vulnerability of People Who Use Drugs (PWUD) to acute stress, the aim of the current study was to better comprehend the impact of covid-19 on quality of life and mental health of PWUD as well as their drug use patterns. Another study had been conducted prior to the covid-19 outbreak, which assessed quality of life, indicative PTSD symptoms, and drug use patterns of people who were attending an Opioid Substitution Treatment (OST), in Athens, Greece. As a continuation of the aforementioned study, the same variables were assessed in May and June 2020, after the first lockdown measures. 104 patients agreed to participate. The World Health Organization Quality of Life Questionnaire (WHOQOL) and the Post-Traumatic Stress Scale (PCL-C) were used as well as toxicology tests. The only statistically significant outcome was a reduction regarding the dimension referring to the relationship between the individual and their environment. People with low quality of life were found to experience more severe Post- Traumatic Stress Disorder (PTSD) symptoms after lockdown comparing to those with high quality of life. There was also a statistically non-significant increase in PTSD scores before and after lockdown measures. Regarding drug use patterns, the present research reveals an overall decline in drug use during quarantine. There was a statistically significant decrease in opioid (22.3%) and in benzodiazepine (35%) use after lockdown. Also, a statistically significant increase in mean scores of indicative PTSD symptoms of people who decreased opioid use during and after lockdown measures was found. In regards to amphetamine use, research findings underline a non-significant increase in use (8.7%). The pandemic's impact on the life of people on opioid substitution treatment should be taken into consideration and further studies need to be conducted in order to protect this populations' quality of life and maximize the potential benefits such as reduced access to illicit substances.

Covid-19对阿片类药物替代治疗人群的影响。
鉴于2019冠状病毒病(covid-19)对普通人群生活质量的恶化以及吸毒人员(PWUD)对急性应激的脆弱性,本研究的目的是更好地了解covid-19对PWUD生活质量和心理健康的影响以及他们的药物使用模式。在2019冠状病毒病爆发之前进行了另一项研究,该研究评估了希腊雅典参加阿片类药物替代治疗(OST)的人的生活质量、指示性PTSD症状和药物使用模式。作为上述研究的延续,在第一次封锁措施实施后的2020年5月和6月,对相同的变量进行了评估。104名患者同意参与。采用世界卫生组织生活质量问卷(WHOQOL)和创伤后应激量表(PCL-C),并进行毒理学试验。唯一有统计学意义的结果是个体与环境之间关系的维度降低了。研究发现,与生活质量高的人相比,生活质量低的人在封锁后会经历更严重的创伤后应激障碍(PTSD)症状。在封锁措施前后,创伤后应激障碍得分也有统计学上不显著的增加。关于药物使用模式,目前的研究表明,在隔离期间,药物使用总体下降。封锁后,阿片类药物(22.3%)和苯二氮卓类药物(35%)的使用有统计学意义的显著下降。此外,发现在封锁措施期间和之后减少阿片类药物使用的人的指示性创伤后应激障碍症状的平均得分在统计上显着增加。关于安非他明的使用,研究结果强调使用量没有显著增加(8.7%)。应考虑到这一流行病对接受类阿片替代治疗的人的生活的影响,并需要进行进一步的研究,以保护这一人群的生活质量,并最大限度地发挥减少获取非法药物等潜在益处。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Psychiatrike = Psychiatriki
Psychiatrike = Psychiatriki Medicine-Medicine (all)
CiteScore
2.60
自引率
0.00%
发文量
37
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信